Elena Ridloff

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

KYMR

Current role

Board Member

2021-01-01–present

SION

Current role

Board Member

2021-01-01–present

ACAD

CFO

6 calls Latest call 2021-08-04

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Sionna Therapeutics, Inc. (SION)	C.F.A. Chief Financial Officer	$506,677	—	—	$2,085,765	$254,925	$10,000	$2,857,367
2024	Sionna Therapeutics, Inc. (SION)	C.F.A. Chief Financial Officer and Head of Corporate Development	$449,946	—	—	$652,725	$197,976	—	$1,300,647
2023	Sionna Therapeutics, Inc. (SION)	C.F.A. Chief Financial Officer and Head of Corporate Development	$432,640	—	—	—	$190,362	—	$623,002
2021	Acadia Pharmaceuticals Inc (ACAD)	Chief Financial Officer	$398,871	—	$978,784	$989,523	—	$22,096	$2,389,704
2020	Acadia Pharmaceuticals Inc (ACAD)	Chief Financial Officer	$462,000	—	$932,316	$935,316	$169,698	$14,840	$2,514,170
2019	Acadia Pharmaceuticals Inc (ACAD)	Chief Financial Officer	$444,026	—	$652,165	$649,614	$229,324	$15,737	$1,990,867

Earnings-call appearances and filed executive appointments or departures, newest first.